Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

6BIO

Inibitor of phosphoinositide-dependent kinase 1 and GSK
 
ALX-430-156-M001 1 mg 90.00 USD
 
ALX-430-156-M005 5 mg 177.00 USD
Do you need bulk/larger quantities?
 
Inhibitor of phosphoinositide-dependent kinase 1 (PDK1). Potent, reversible and ATP-competitive inhibitor of glycogen synthase kinase-3α/β (GSK-3α/β) (IC50=5nM). Maintains self-renewal and pluripotency in embryonic stem cells via activation of Wnt in vitro. Promotes proliferation and dedifferentiation in cardiomyocytes.

Product Details

Formula:C16H10BrN3O2
 
MW:356.2
 
CAS:667463-62-9
 
Purity:≥98% (HPLC)
 
Appearance:Dark red solid.
 
Solubility:Soluble in DMSO.
 
Shipping:Ambient Temperature
 
Long Term Storage:+4°C
 
Handling:Protect from light.
 
Regulatory Status:RUO - Research Use Only
 
430-156
Please mouse over
430-156

Product Literature References

Adipose-derived mesenchymal stem cells promote salivary duct regeneration via a paracrine effect: S. Kang, et al.; J. Oral. Biosci. 65, 104 (2023), Abstract;
Wnt/β-Catenin Protects Lymphocytes from HIV-Mediated Apoptosis via Induction of Bcl-xL: Y.A. Albalawi, et al.; Viruses 14, 1469 (2022), Abstract;
Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production: A. Valerio, et al.; J. Neurochem. 116, 1148 (2011), Abstract;
Anticancer effects and antimetastatic mechanisms of novel indirubin derivatives: C.A. Kressirer; (2010), (PhD thesis), Full Text
Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover: R. Yasuhara, et al.; J. Biol. Chem. 285, 317 (2010), Abstract; Full Text
Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A: L. Martin, et al.; Brain Res. 1252, 66 (2009), Abstract;
An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins: V. Myrianthopoulos, et al.; J. Med. Chem. 50, 4027 (2007), Abstract;
Inverse in silico screening for identification of kinase inhibitor targets: S. Zahler, et al.; Chem. Biol. 14, 1207 (2007), Abstract;
7-Bromoindirubin-3’-oxime induces caspase-independent cell death: J. Ribas, et al.; Oncogene 25, 6304 (2006), Abstract;
The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes: A.S. Tseng, et al.; Chem. Biol. 13, 957 (2006), Abstract;
Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases: P. Polychronopoulos, et al.; J. Med. Chem. 47, 935 (2004), Abstract;
GSK-3-selective inhibitors derived from Tyrian purple indirubins: L. Meijer, et al.; Chem. Biol. 10, 1255 (2003), Abstract;

Related Products

Indirubin-3'-monoxime 

Inhibitor of CDK and GSK
160807-49-8, ≥98% | Print as PDF
 
BML-CC207-0001 1 mg 106.00 USD
 
BML-CC207-0005 5 mg 439.00 USD
Do you need bulk/larger quantities?
 

Indirubin-5-sulfonic acid . sodium salt 

Inhibitor of CDK and GSK
≥95% (1H-NMR) | Print as PDF
 
ALX-270-296-M001 1 mg 108.00 USD
Do you need bulk/larger quantities?
 

Indirubin 

Inhibitor of CDK and GSK
479-41-4, Synthetic., ≥97% (HPLC) | Print as PDF
 
ALX-270-361-M001 1 mg 70.00 USD
 
ALX-270-361-M005 5 mg 316.00 USD
Do you need bulk/larger quantities?
 

5-Iodo-indirubin-3'-monoxime 

Inhibitor of GSK and CDK/cyclin
≥98% (TLC) | Print as PDF
 
ALX-270-424-M001 1 mg 145.00 USD
Do you need bulk/larger quantities?
 

Me-7BIO 

≥98% | Print as PDF
 
ALX-430-157-M001 1 mg 139.00 USD
Do you need bulk/larger quantities?
 

Related Literature

Brochures
Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

Brochures
Stem Cells
Stem Cells
Download as PDF

Brochures
Neurodegeneration
Neurodegeneration
Download as PDF

All new literature pieces